PlainRecalls
FDA Drug Moderate Class II Terminated

VERAPAMIL HCL ER, Capsule, 240 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378644001.

Reported: January 29, 2014 Initiated: July 2, 2013 #D-908-2014

Product Description

VERAPAMIL HCL ER, Capsule, 240 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378644001.

Reason for Recall

Labeling: Label Mixup: VERAPAMIL HCL ER, Capsule, 240 mg may have potentially been mislabeled as the following drug: FEBUXOSTAT, Tablet, 40 mg, NDC 64764091830, Pedigree: W002664, EXP: 6/5/2014.

Details

Recalling Firm
Aidapak Services, LLC
Units Affected
100 Capsules
Distribution
Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Location
Vancouver, WA

Frequently Asked Questions

What product was recalled?
VERAPAMIL HCL ER, Capsule, 240 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378644001.. Recalled by Aidapak Services, LLC. Units affected: 100 Capsules.
Why was this product recalled?
Labeling: Label Mixup: VERAPAMIL HCL ER, Capsule, 240 mg may have potentially been mislabeled as the following drug: FEBUXOSTAT, Tablet, 40 mg, NDC 64764091830, Pedigree: W002664, EXP: 6/5/2014.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 29, 2014. Severity: Moderate. Recall number: D-908-2014.